D. Soucier-Ernst

Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.

Noah D. Goodman, Matt R. Paul, Tien-chi Pan, 2020, The Journal of clinical investigation.

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Matt R. Paul, Tien-chi Pan, L. Chodosh, 2017, Breast Cancer Research and Treatment.

Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Matt R. Paul, Tien-chi Pan, L. Chodosh, 2017, Breast Cancer Research and Treatment.